» Articles » PMID: 39267611

Systematic Transcriptomic Analysis and Temporal Modelling of Human Fibroblast Senescence

Overview
Journal Front Aging
Specialty Geriatrics
Date 2024 Sep 13
PMID 39267611
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular senescence is a diverse phenotype characterised by permanent cell cycle arrest and an associated secretory phenotype (SASP) which includes inflammatory cytokines. Typically, senescent cells are removed by the immune system, but this process becomes dysregulated with age causing senescent cells to accumulate and induce chronic inflammatory signalling. Identifying senescent cells is challenging due to senescence phenotype heterogeneity, and senotherapy often requires a combinatorial approach. Here we systematically collected 119 transcriptomic datasets related to human fibroblasts, forming an online database describing the relevant variables for each study allowing users to filter for variables and genes of interest. Our own analysis of the database identified 28 genes significantly up- or downregulated across four senescence types (DNA damage induced senescence (DDIS), oncogene induced senescence (OIS), replicative senescence, and bystander induced senescence) compared to proliferating controls. We also found gene expression patterns of conventional senescence markers were highly specific and reliable for different senescence inducers, cell lines, and timepoints. Our comprehensive data supported several observations made in existing studies using single datasets, including stronger p53 signalling in DDIS compared to OIS. However, contrary to some early observations, both p16 and p21 mRNA levels rise quickly, depending on senescence type, and persist for at least 8-11 days. Additionally, little evidence was found to support an initial TGFβ-centric SASP. To support our transcriptomic analysis, we computationally modelled temporal protein changes of select core senescence proteins during DDIS and OIS, as well as perform knockdown interventions. We conclude that while universal biomarkers of senescence are difficult to identify, conventional senescence markers follow predictable profiles and construction of a framework for studying senescence could lead to more reproducible data and understanding of senescence heterogeneity.

Citing Articles

Emerging insights in senescence: pathways from preclinical models to therapeutic innovations.

Mansfield L, Ramponi V, Gupta K, Stevenson T, Mathew A, Barinda A NPJ Aging. 2024; 10(1):53.

PMID: 39578455 PMC: 11584693. DOI: 10.1038/s41514-024-00181-1.

References
1.
Xu S, Cai Y, Wei Y . mTOR Signaling from Cellular Senescence to Organismal Aging. Aging Dis. 2014; 5(4):263-73. PMC: 4113516. DOI: 10.14336/AD.2014.0500263. View

2.
Alcorta D, Xiong Y, Phelps D, Hannon G, Beach D, Barrett J . Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A. 1996; 93(24):13742-7. PMC: 19411. DOI: 10.1073/pnas.93.24.13742. View

3.
Georgilis A, Klotz S, Hanley C, Herranz N, Weirich B, Morancho B . PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells. Cancer Cell. 2018; 34(1):85-102.e9. PMC: 6048363. DOI: 10.1016/j.ccell.2018.06.007. View

4.
Park J, Ryu S, Kim B, Cho H, Park C, Choi H . Disruption of nucleocytoplasmic trafficking as a cellular senescence driver. Exp Mol Med. 2021; 53(6):1092-1108. PMC: 8257587. DOI: 10.1038/s12276-021-00643-6. View

5.
Raffaele M, Vinciguerra M . The costs and benefits of senotherapeutics for human health. Lancet Healthy Longev. 2022; 3(1):e67-e77. DOI: 10.1016/S2666-7568(21)00300-7. View